DSM

Companies DSM

News DSM

• DSM and Chemtrix sign collaboration agreement in Continuous Flow Chemistry

  DSM Pharmaceutical Products announced that it has signed a collaboration agreement with Chemtrix B.V. in the field of Continuous Flow Chemistry to provide sustainable equipment and, development and manufacturing services to the pharmaceutical industry. The agreement brings together the expertise of more

• DSM Announces Biologics Development and Manufacturing Agreement for Australian Facility

  DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with Paranta Biosciences Ltd of Melbourne , Australia.The contract covers the process development and cGMP manufacture by DSM of Paran more

• DSM Sinochem Pharmaceuticals opens new 6-APA intermediate plant in China

  In the presence of the governor of Jilin province, Mr. Wang Rulin, the opening ceremony of DSM Sinochem Pharmaceuticals’ newest intermediate plant was celebrated in YuShu, China. The new plant will produce the beta-lactam intermediate 6-APA (6- Aminopenicillanic Acid) for global markets. 6-APA is th more

Publications DSM

• Root endophyte Piriformospora indica DSM 11827 alters plant morphology, enhances biomass and antioxidant activity of medicinal plant Bacopa monniera

  Abstract Unorganized collections and over exploitation of naturally occurring medicinal plant Bacopa monniera is leading to rapid depletion of germplasm and is posing a great threat to its survival in natural habitats. The species has already been listed in the list of highly threatened plants more

• Dynamics of amino acid utilization in Phaeobacter inhibens DSM 17395

  Time‐resolved utilization of multiple amino acids by Phaeobacter inhibens DSM 17395 was studied during growth with casamino acids. The 15 detected amino acids could be grouped according to depletion rate into four different categories, i.e. from rapid (category I) to non‐depletion (category IV). U more

• Adaptation of Phaeobacter gallaeciensis DSM 17395 to growth with complex nutrients

  Phaeobacter gallaeciensis DSM 17395, a member of the Roseobacter clade, was studied for its adaptive strategies to complex and excess nutrient supply, here mimicked by cultivation with Marine Broth (MB). During growth in process‐controlled fermenters, P. gallaeciensis grew faster (3.6‐fold higher more

Market studies DSM

• Global Active Pharmaceutical Ingredients Market 2011-2015

  TechNavio's analysts forecast the Global Active Pharmaceutical Ingredient market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel formulation technologies. The Global Active Pharmaceutical Ingredient market ha more

• DSM Dyneema B.V. - Strategic SWOT Analysis Review

  DSM Dyneema B.V. - Strategic SWOT Analysis Review Summary DSM Dyneema B.V. (DSM Dyneema) is engaged in the manufacture and marketing of the world’s strongest fiber marketed under the Dyneema brand. Dyneema is a polyethylene fiber that provides maximum strength with less weight. It finds applicatio more

• Aqua Bounty Technologies, Inc. (ABTX) - Financial and Strategic SWOT Analysis Review

  Aqua Bounty Technologies, Inc. (Aqua Bounty) is a publicly held biotechnology company, engaged in the research, development, and commercialization of therapeutic and diagnostic products for the aquaculture industry. It is also involved in developing AquAdvantage Salmon, a hybrid salmon. In addition, more

Websites DSM